A Prospective Study of Estrogen Replacement Therapy and the Risk of Developing Alzheimer's Disease
Neurol 48:1517-1521, Kawas,C.,et al, 1997
Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997
Comparison of CT and MR Features with Clinical Outcome in Patients with Rocky Mountain Soptted Fever
AJNR 18:459-464, Bonawitz,C.,et al, 1997
Diagnosis and Management of Neurological Sarcoidosis
Arch Int Med 157:1864-1868, Lower,E.E.,et al, 1997
Ataxia and Slurred Speech after Artesunate Treatment for Falciparum Malaria
NEJM 336:1328, Miller,L.G.&Panosian,C.B., 1997
Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997
Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997
Aluminum Neurotoxicity in Preterm Infants Receiving Intravenous-Feeding Solutions
NEJM 336:1557-1561, Bishop,N.J.,et al, 1997
Clinicopath Conf
Botulism, Case 22-1997, NEJM 337:184-190997., , 1997
Botulism Surveillance and Emergency Response
JAMA 278:433-435, Shapiro,R.L.,et al, 1997
Confusion after Visiting the Radiology Department
Lancet 350:780, Devendra,D.,et al, 1997
Frequent & Frequently Overlooked:Trtm-Induced Endocrine Dysf in Adult Long-Term Survivors of Primary Brain Tumors
Neurol 49:498-506, Arlt,W.,et al, 1997
Chemotherapy of Human Malignant Glioma:Prevention of Efficacy by Dexamethasone
Neurol 48:1704-1709, Weller,M.,et al, 1997
Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997
Color Vision Test for Early Detection of Antiepileptic Drug Toxicity
Neurol 48:1394-1397, Bayer,A.U.,et al, 1997
Dietary Antioxidants and Parkinson Disease
Arch Neurol 54:762-765, deRijk,M.C.,et al, 1997
Risk Factors for Postherpetic Neuralgia
Arch Int Med 157:1217-1224, 11661997., Choo,P.W.,et al, 1997
Basal Ganglia Infarction in a Child with Disulfiram Poisoning
Pediatrics 99:605-608, Mahajan,P.&Kottamasu,S., 1997
The Effect of Treating Herpes Zoster with Oral Acyclovir in Preventing Postherpetic Neuralgia
Arch Int Med 157:909-912, Jackson,J.L.,et al, 1997
Cordarone (Amiodarone)
Product Insert, Wyeth-Ayerst Laboratories, June 1997., , 1997
Postoperative Cerebral Edema Occurring in Children with Slit Ventricles
Pediatrics 99:625-630, Eldredge,E.,et al, 1997
Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997
Asymptomatic Pontine Lesions Found by Magnetic Resonance Imaging: Are They Central Pontine Myelinolysis?
J Neurol Sci 149:27-35, Kleinschmidt-Demasters,B.K.,et al, 1997
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C
Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Ganciclovir-Induced Psychosis
NEJM 335:1937, Hansen,B.A.,et al, 1996
Immunosuppression-Induced Leukoencephalopathy from Tacrolimus (FK506)
Ann Neurol 40:575-580, Small,S.L.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Botulinum Toxin:A Deadly Poison Sheds its Negative Image
Ann Int Med 125:616-617, Simpson,L.L., 1996
Tissue-Type Plasminogen Activator Should Not be Used in Acute Ischemic Stroke
Arch Neurol 53:1306-1308, Riggs,J.E., 1996
Thrombolysis for Stroke
Arch Neurol 53:1305-1306, 13081996., Brott,T., 1996
TPA Within 3 Hours of Acute Ischaemic Stroke
Lancet 348:1600-1601, Dorman,P.&Sandercock,P., 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Thrombolysis in Acute Stroke, Defining Risk to Benefit Ratio
BMJ 313:640-641, Bogousslavsky,J., 1996
Progressive Encephalomyelitis with Rigidity Responsive to Plasmapheresis and Immunosuppression
Ann Neurol 40:451-453, Fogan,L., 1996
Varicella Zoster Virus, A Cause of Waxing and Waning Vasculitis:The NEJM Case 5-1995 Revisited
Neurol 47:1441-1446, Gilden,D.H.,et al, 1996
Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996
Good Clinical Outcome in a Pt with Large CT Scan Hypodensity Treated with Intra-Arterial Urokinase after Embolic Stroke
Neurol 47:1076-1078, Tarr,R.,et al, 1996
Streptokinase for Acute Ischemic Stroke with Relationship to Time of Administration
JAMA 276:961-966, 9951996., Donnan,G.A.,et al, 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996
Peripheral Neuropathy Secondary to Docetaxel (Taxotere)
Neurol 46:108-111, 21996., New,P.Z.,et al, 1996
Peripheral Neurotoxicity Induced by Docetaxel
Neurol 46:104-108, 21996., Hilkens,P.H.E.,et al, 1996
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996
Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Concern About Safety of Carotid Angioplasty
Stroke 27:197-198, Beebe,H.G.,et al, 1996
Lubeluzole in Acute Ischemic Stroke:A Double-Blind Placebo-Controlled Phase II Trial
Stroke 27:76-81, Diener,H.C.,et al, 1996